Human Immunodeficiency Virus Type 1 Entry Inhibitors Selected on Living Cells from a Library of Phage Chemokines
暂无分享,去创建一个
P. Debré | R. Offord | F. Cerini | H. Gaertner | O. Hartley | G. Pancino | G. Gorochov | K. Dorgham | D. Perez-Bercoff | A. Heimann
[1] T. Hope,et al. Association of Chemokine-mediated Block to HIV Entry with Coreceptor Internalization* , 2002, The Journal of Biological Chemistry.
[2] T. Schwartz,et al. Molecular Determinants of Receptor Binding and Signaling by the CX3C Chemokine Fractalkine* 210 , 2001, The Journal of Biological Chemistry.
[3] Menico Rizzi,et al. Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES , 2001, Nature Structural Biology.
[4] S. Ferguson,et al. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. , 2001, Pharmacological reviews.
[5] O. Chaloin,et al. Donor- and Ligand-Dependent Differences in C-C Chemokine Receptor 5 Reexpression , 2001, Journal of Virology.
[6] R. Nibbs,et al. Aminooxypentane Addition to the Chemokine Macrophage Inflammatory Protein-1αP Increases Receptor Affinities and HIV Inhibition* , 2000, The Journal of Biological Chemistry.
[7] M. Bolognesi,et al. Enhancement of the HIV‐1 inhibitory activity of RANTES by modification of the N‐terminal region: dissociation from CCR5 activation , 2000, European journal of immunology.
[8] John P. Moore,et al. New targets for inhibitors of HIV-1 replication , 2000, Nature Reviews Molecular Cell Biology.
[9] R. Offord,et al. Amino-terminally Modified RANTES Analogues Demonstrate Differential Effects on RANTES Receptors* , 1999, The Journal of Biological Chemistry.
[10] K. Jarnagin,et al. Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2. , 1999, Biochemistry.
[11] B. Walker,et al. Enhanced Inhibition of Human Immunodeficiency Virus Type 1 by Met-Stromal-Derived Factor 1β Correlates with Down-Modulation of CXCR4 , 1999, Journal of Virology.
[12] Pascal Poignard,et al. Highly Potent RANTES Analogues either Prevent CCR5-Using Human Immunodeficiency Virus Type 1 Infection In Vivo or Rapidly Select for CXCR4-Using Variants , 1999, Journal of Virology.
[13] J. Marks,et al. Targeted gene delivery to mammalian cells by filamentous bacteriophage. , 1999, Journal of molecular biology.
[14] C. Combadière,et al. Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1. , 1998, The Journal of biological chemistry.
[15] M. Mack,et al. Aminooxypentane-RANTES Induces CCR5 Internalization but Inhibits Recycling: A Novel Inhibitory Mechanism of HIV Infectivity , 1998, The Journal of experimental medicine.
[16] N. Skelton,et al. Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3 and CCR5. , 1997, Biochemistry.
[17] M. Locati,et al. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation. , 1997, Virology.
[18] B. Cullen,et al. Molecular mechanism of desensitization of the chemokine receptor CCR‐5: receptor signaling and internalization are dissociable from its role as an HIV‐1 co‐receptor , 1997, The EMBO journal.
[19] Jean Salamero,et al. HIV Coreceptor Downregulation as Antiviral Principle: SDF-1α–dependent Internalization of the Chemokine Receptor CXCR4 Contributes to Inhibition of HIV Replication , 1997, The Journal of experimental medicine.
[20] N. Heveker,et al. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. , 1997, Science.
[21] T. Schwartz,et al. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. , 1997, Science.
[22] M. Baggiolini,et al. HIV blocked by chemokine antagonist , 1996, Nature.
[23] Bernhard Moser,et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 , 1996, Nature.
[24] J. Sodroski,et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry , 1996, Nature.
[25] B. Dewald,et al. RANTES and MCP-3 Antagonists Bind Multiple Chemokine Receptors (*) , 1996, The Journal of Biological Chemistry.
[26] M. Montjovent,et al. Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist (*) , 1996, The Journal of Biological Chemistry.
[27] S. Arya,et al. Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.
[28] Greet Vanhoof,et al. Proline motifs in peptides and their biological processing , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] R. Connor,et al. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. , 1995, Virology.
[30] H R Hoogenboom,et al. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. , 1991, Nucleic acids research.
[31] R. Tsien,et al. A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.
[32] J. Farber,et al. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.
[33] A. Wlodawer,et al. Total chemical synthesis and high-resolution crystal structure of the potent anti-HIV protein AOP-RANTES. , 1999, Chemistry & biology.
[34] W. Stemmer,et al. Construction and evolution of antibody–phage libraries by DMA shuffling , 1996, Nature Medicine.
[35] S. Arya,et al. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. , 1995, Science.